Seok-Joo Moon

Seok-Joo Moon

Auto-generated profile, based on publicly available information

Seok-Joo Moon

Department of Biostatistics, Korea University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DKDae-Hyun Kim
Dae-Hyun Kim
SMSeok-Joo Moon
Seok-Joo Moon
JLJuneyoung Lee
Juneyoung Lee
JCJae-Kwan Cha
Jae-Kwan Cha
MKMoo Hyun Kim
Moo Hyun Kim
HBHee-Joon Bae
Hee-Joon Bae
Kim DH, et al. J Korean Med Sci. 2022 Oct;37(42):e305. https://doi.org/10.3346/jkms.2022.37.e305

1 January 2023 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
JPJun-Gu Park
Jun-Gu Park
Seung-Beom HanSeung-Beom Han
Seung-Beom Han
JPJong-Hoon Park
Jong-Hoon Park
SMSeok-Joo Moon
Seok-Joo Moon
WJWoo Young Jang
Woo Young Jang
Park JG, et al. Clin Orthop Surg. 2023 Oct;16:e70. https://doi.org/10.4055/cios22312

16 November 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
SMSeok-Joo Moon
Seok-Joo Moon
SASeohyun Ahn
Seohyun Ahn
YLYunJeong Lee
YunJeong Lee
SJSo-Youn Jung
So-Youn Jung
HKHyun-Jin Kim
Hyun-Jin Kim
Background: Cancer survivors have an elevated cardiovascular disease (CVD) risk. Existing evidence is often limited by cross-sectional designs or single-cancer focus, hindering systematic comparisons across different cancer types. We examined cancer type-specific patterns of association between cardiovascular risk factors and incident CVD. Methods: This nationwide cohort study utilized the Korea-Clinical Data Utilization Network for Research Excellence database, including 148,537 survivors of breast, colorectal, gastric, liver, or lung cancers (2012–2021). Primary outcome was incident CVD (ischemic heart disease [IHD] or stroke). Cause-specific Cox models were used to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs), with death as a competing risk. Results: Age, hypertension, and diabetes were significant predictors of incident CVD across all cancer types. Heavy smoking was associated with a high CVD risk in survivors of breast (aHR, 1.93; 95% CI, 1.29–2.89) and colorectal cancers (1.42; 1.26–1.60). Severe obesity (body mass index ≥ 30 kg/m²) was associated with a high CVD risk in survivors of breast (1.25; 1.07–1.47) and liver cancers (1.32; 1.03–1.69), and with incident IHD across all cancer types, but most strongly in liver and lung cancers. Incident stroke was more strongly associated with advanced tumor stage (aHR range, 1.59–2.13) than with obesity. Conclusions: Cardiovascular risk factor associations vary by cancer type and CVD subtype, supporting the use of tailored, cancer type-specific risk-reduction strategies in survivorship care. Impact: These findings provide an evidence base for cancer-specific cardiovascular risk stratification in survivorship care.